Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
BACKGROUND: Neuromyelitis optica (NMO) is a severe autoimmune inflammatory disorder associated with considerable relapse-related disability. Immunosuppression is the mainstay of treatment but many patients do not tolerate first-line immunosuppressive agents, or experience ongoing relapses. OBJECTIV...
主要な著者: | Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2013
|
類似資料
-
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
著者:: Kitley, J, 等
出版事項: (2013) -
METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
著者:: Kitley, J, 等
出版事項: (2012) -
Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
著者:: Kitley, J, 等
出版事項: (2013) -
TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
著者:: Elsone, L, 等
出版事項: (2012) -
Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
著者:: Kitley, J, 等
出版事項: (2013)